(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

5 QBD-BIOTECH HUMMINGBIRD ADDED VALUE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

5 QBD-BIOTECH HUMMINGBIRD ADDED VALUE

ST13

US500000088813080

Class

5, 35, 41, 42

Filing

88813080

Registration

7102647

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

44

Latest update

07/11/2023

Trademark type

Combined

Nice classes

5, 35, 41, 42

Filing date

02/27/2020

Registration date

07/11/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/11/2023

Last transaction

07/11/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

Drawing code

3

Owner type

01

Owner location

Aydat, FR

Examiner

REEVES, APRIL ELIZABETH

Law office

N60

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of an illustration of a hummingbird with one purple wing, one orange wing, a yellow head, green body, and blue tail. Next to the hummingbird are the words '5 QBD-BIOTECH' in black. Under those words are the words 'HUMMINGBIRD ADDED VALUE' in black.

Holders and representatives

Holders

F. V. (pessoa física)

Representatives

Hope V. Shovein BROOKS KUSHMAN P.C.

Technical classification

Nice Classes

Class 5Class 35Class 41Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Animal feed additives for use as nutritional supplements intended for veterinary use; anti diabetic pharmaceuticals; diagnostic kits consisting primarily of monoclonal antibodies for therapies as cancer; chemical preparations for pharmaceutical usepharmaceutical preparations for the prevention and treatment of cancerfor the treatment of viral and infectious diseases; chemical preparations for the diagnosis of diabetes; chemicopharmaceutical productspharmaceutical preparations for the prevention and treatment of cancerfor the treatment of viral and infectious diseases; dermatological pharmaceutical products; diagnostic radiopharmaceutical preparations; dietetic foods for medical use; dietetic foodstuffs for veterinary use; food for babies; herbal teas for medicinal purposes; intravenous fluid for rehydrationnutrition and the delivery of pharmaceuticals; medicated shampoos; nutritional additives for use as nutritional supplements intended for animal feed for medical use; nutritional supplements for foodstuffs for livestock; nutritional supplements for veterinary use; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of animal diseasesfor metabolic disorders and infectious diseases caused by virusesbacteriafungiparasitescancerauto-immune diseases for human diseases; probiotic bacterial formulations for medical use; probiotic bacterial formulations for veterinary use; probiotic preparations for medical use to help maintain a natural balance of the intestinal flora in the digestive system; radiopharmaceutical productsdiagnostic and therapeutic radiopharmaceutical preparations for cancer and infectious diseases; release agents in the nature of tablet coatings which facilitate the release of nutritional supplements; sanitary preparations for medical use; syringes pre-filled with pharmaceutical preparations for use in chemotherapy for medical usemetabolic disorders and infectious diseases caused by virusesbacteriafungiparasitescancerauto-immune diseases; veterinary productsveterinary pharmaceutical preparations for the prevention of metabolic disorders and infectious diseases caused by virusesbacteriafungiparasites

Class 35

Advertising services for pharmaceuticals intended for the treatment of diabetes; advertising services with respect to pharmaceuticals; advice in the field of businessin the field of company organization and economics; advice on corporate organization and management; business management and organization consultancy; collection and systematization of information in computer databases; collection of information with respect to market research; commercial business management; compilation and systematization of information in databases; compilation of information for commercial purposes; compilation of scientific information into computer databases; consultancy relating to business management; preparation of business reports and market research; wholesale and retail store services featuring pharmaceuticalveterinary and sanitary preparations and medical supplies; business management for freelance service providers

Class 41

Advice with respect to medical training; advice with respect to training; career coaching services; consultancy with respect to professional training; continuous business training; arranging of professional training courses; industrial trainingtraining in industrialization roadmapsprocess developmentgood manufacturing practices and regulatory compliance; virtual or presential training services in the field of nutrition; arranging and conducting educational congressescolloquiumsconferencesseminarsworkshops in the field of science and technologymore specifically industrial productionbiotechnology and pharmaceutical productionquality system development and implementationbiotechnologymicrobiologybiologic therapeutic productsalternative diagnostics and detection methods; Entertainment and educational services in the nature of organizing and conducting competitions in the field of educationresearch and technology development; educational servicesconducting courses of instruction in the field of nutrition; organization of exhibitions for cultural or educational purposes; educational servicesconducting seminarscourses of instructioneducational symposiums in training methodologies; personal trainer services; personnel training in the field of food technologies; publication of journals featuring clinical trial results regarding pharmaceutical preparations; publication of specialized journals in scientific information; training consultancy; training services in the field of medicalmicrobiologicalpharmaceuticalnutritionalbiotechnological research and developmentlaboratory practices for research and developmentmanufacturing

Class 42

Advisory services in the field of biotechnologyquality control technologypharmaceutical and biotherapeutic products developmentprocess development; Bacteriological analyses; bacteriological research and analysis; bacteriological research; bacteriological research services; basic and clinical research in the field of respiratory science and medicine; biochemical research and development; biochemical research; biological research services; biological and medical research services; Clinical research in the field of radiologybiotherapeutic productscancer therapiesviral-based therapiesgene and cell-based therapies; biomedical research services; biotechnological research linked to enzymatic synthesis; biotechnological research linked with the industry; biotechnological research relating to the gasoline industry; biotechnological research; carrying out clinical trials for pharmaceutical products; chemical research; Conducting feasibility studies in the field of bioprocess engineering; bacteriological research and consulting in the field of bacteriological research; consultancy in the field of industrial research; consultancy in the field of pharmaceutical research; consultancy with respect to bacteriology research; consultancy with respect to bacteriology; consultancy with respect to pharmaceutical research and development; design and development of medical diagnostic apparatus; development of pharmaceutical preparations and medicines; development of pharmaceutical products; development services for pharmaceutical products; engineering consultancy in the field of design; engineering consultancy in the field of testings; engineering research; evaluation of the efficacy of pharmaceutical products; scientific research in the field of genetics and its respective therapies; Industrial research in the field of scientific and medical apparatus and machines; information about scientific research in the field of biochemistry and biotechnology; inspection of pharmaceutical products; laboratory analysis in the field of bacteriology; laboratory research in the field of genetic expression; laboratory research services concerning pharmaceutical products; Laboratory research in the field of biotechnology productsrecombinant DNA technologybiomass productionprotein productioncell and gene therapiesprobiotics; pharmaceutical research and development services; preparation of reports concerning industrial design and scientific research and development for scientific research purposes; product research; providing information and data with respect to medical and veterinary research and development; providing information and results relating to scientific research from an online searchable database; providing scientific information in the field of medical disorders and their treatment; provision of information about industrial analysis and research services; provision of information concerning design and development of computer softwarenetworks and systems; provision of information concerning the results of clinical trials for pharmaceutical products; provision of information in the field of medical and scientific research in the field of pharmaceutical products and clinical trials; provision of information relating to technological research; qualitative evaluation of pharmaceutical products; pharmaceutical research and development for the pharmaceutical industry; research and development in the field of antibodies; research and development in the field of biotechnology; research and development in the field of diagnostic preparations; research and development in the field of microorganisms and cells; research and development in the field of pharmaceuticals and biotechnology; research and development of new products for third parties; research and development of new productson behalf of third partiesin the field of plastics; research and development of new products; research and development of products; research and development of vaccines and medicines; research and development services in the field of antibody technology; research and development services in the field of bacteriology; research and development services in the field of chemistry; research and development services in the field of cytology; research and development services in the field of engineering; research and development services in the field of gene expression systems; research and development services in the field of immunohistology; research and development services in the field of immunology; research and development services with respect to vaccines; research on food products; Industrial research in the field of bioprocessesunit operationsupstream/downstream processesaseptic processcontamination control strategy and apparatus; research in the field of food; product research in the field of instrumentation; product research in the field of pharmaceutical products; product research linked to bacteriology; product research relating to design; product research with respect to computer program and software development; product research with respect to medicines; product research with respect to pharmaceuticals; researchdevelopmentdesign and updating of software; Scientific and technological servicesscientific analysis in the field of microbiology and biotechnology; scientific and industrial research in the field of microbiology and biotechnology; scientific research and development; scientific research concerning cosmetic products; scientific research for medical purposes; scientific research in the field of chemistry; scientific research in the field of pharmacy; scientific research linked to bacteriology; scientific research services; product development services for conducting early assessments of new pharmaceuticals; scientific research services provided by consultants in the field of scientific research; stem cell research; support services with respect to information technologymonitoring technological functions of computer network systems to ensure data integrity; technical consultancy with respect to product development; technical consulting relating to research services concerning food and dietary supplements; technical consulting relating to technical research in the field of food and beverages; Technical consultation in the field of process development and quality by design regarding biotechnological and pharmaceutical products; technical research in the field of pharmaceutical and biotechnological studies; technological consultancy services in the technology field of industrial productionequipment and bioanalysis; testing on pharmaceutical products

Publications

History of USPTO decisions and trademark events.

44 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/11/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

07/11/2023

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

06/05/2023

IUCN

NOTICE OF ALLOWANCE CANCELLED

04/25/2023

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

04/25/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/19/2023

D1BR

TEAS DELETE 1(B) BASIS RECEIVED

04/19/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

04/19/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

10/25/2022

ETOP

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

09/15/2022

CHPB

POST PUBLICATION AMENDMENT - ENTERED

09/14/2022

APET

ASSIGNED TO PETITION STAFF

09/09/2022

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

08/22/2022

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

03/09/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/08/2022

PUBO

PUBLISHED FOR OPPOSITION

03/08/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/16/2022

ALIE

ASSIGNED TO LIE

02/01/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/31/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/31/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/30/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/30/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/16/2021

GNRT

NON-FINAL ACTION E-MAILED

08/16/2021

CNRT

NON-FINAL ACTION WRITTEN

08/16/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/09/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/08/2021

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

07/08/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/05/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/03/2021

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

07/03/2021

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

01/09/2021

GNFR

FINAL REFUSAL E-MAILED

01/09/2021

CNFR

FINAL REFUSAL WRITTEN

01/09/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/04/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/03/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/03/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/03/2020

GNRT

NON-FINAL ACTION E-MAILED

06/03/2020

CNRT

NON-FINAL ACTION WRITTEN

06/03/2020

DOCK

ASSIGNED TO EXAMINER

05/18/2020

MDSM

NOTICE OF DESIGN SEARCH CODE E-MAILED

03/10/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/08/2020

NWAP

NEW APPLICATION ENTERED

03/05/2020

Continuous trademark protection

Get notified about every new filing that threatens 5 QBD-BIOTECH HUMMINGBIRD ADDED VALUE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.